Planned enrollment decreased by 10 participants
Before: 40 participants (planned). After: 30 participants (planned).
Primary completion date changed
Before: Dec 2026. After: Jun 2027.
Study sponsor: 4D Molecular Therapeutics
Primary completion is the date data collection ends for the main study measures, not when results are published.
Before: 40 participants (planned). After: 30 participants (planned).
Before: Dec 2026. After: Jun 2027.
Before: PHASE1, PHASE2. After: PHASE2.